DUBLIN–(BUSINESS WIRE)–The “AAV vectors in gene therapy – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. AAV vectors in gene therapy: Overview Out of the several viral vectors that have been used to date for delivering the genes of interest, the Adeno-associated viral (AAV) vector appears to be the safest and effective … [Read more…]
AI Showcase Theater Presentation: “Enabling Lung Cancer Screening with iBiopsy® AI-based Software as Medical Device” Scientific Presentation: ”Development of an AI/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers” Virtual Poster Presentation: “Discordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Investigative Site Network Market Size, Share & Trends Analysis Report by Therapeutic Areas (Oncology, CNS), by Phase (Phase I, III), by End-use (Sponsor, CRO), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global clinical trial investigative site network market size is expected to reach USD … [Read more…]
Samsung to highlight its innovations and advancements across ultrasound, digital radiography and mobile computed tomography modalities. DANVERS, Mass.–(BUSINESS WIRE)–Samsung Electronics Co. Ltd. will be unveiling its latest artificial intelligence (AI) technologies and presenting its premium diagnostic solutions in ultrasound, digital radiography (DR) and mobile computed tomography (CT) at the Radiological Society of North America (RSNA) … [Read more…]
Personalized Therapy Biosimulation Identifies m-MGMT GBM Patients Who Will Develop Early Progression on Temozolomide SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cellworks Group Inc., a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a Cellworks biosimulation pilot study, which examined the impact of mismatch repair deficiency (MRD) on survival of temozolomide (TMZ)-treated patients … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Women’s Health Diagnostics Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. Global Women’s Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-Users … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Fertility Test Market Analysis, Product, by Mode of Purchase, by Application, by End User, by and by Region – Global Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. The fertility test market size is estimated to be USD 498.65 million in 2021 and is expected to witness a CAGR of 7.91% … [Read more…]
– Inspired by the stories of real patients, the “Topical Uprising” campaign taps into the frustrations experienced by plaque psoriasis patients and how VTAMA cream can help – – VTAMA cream is the first and only steroid-free, FDA-approved medication in its class for adults with plaque psoriasis and is currently the #1 prescribed branded topical … [Read more…]
Bamboo Health’s Pings solution provides Real-Time Care Intelligence™ to help expedite access to treatment for individuals with substance use disorder LOUISVILLE, Ky.–(BUSINESS WIRE)–Bamboo Health™, the leader in Real-Time Care Intelligence™, announced today that Aware Recovery Care, a leading provider of in-home addiction treatment services, has selected Bamboo Health to help expedite access to care and … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Synthetic Biology Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global synthetic biology market is anticipated to grow at a substantial CAGR of 32.0% during the forecast period. Increased research and development funding for synthetic biology research and declining cost of DNA sequencing & synthesizing are the major factors driving … [Read more…]
